Phase 1 Start~month

Phase 1 Start: A Phase I, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokin

Indication
Staphylococcus Aureus Bloodstream Infection

Other upcoming events for AZN

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Multi-center, Open-label Study of Trastuzumab Deruxtecan (T-DXd) Versus Inves
Phase 3 ReadoutPhase 3 Topline: A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Fulves
Phase 3 ReadoutPhase 3 Topline: A Phase III Randomized, Open-Label, Multi-Center Study of Durvalumab (MEDI4736) Versus Standard of C
Phase 3 ReadoutPhase 3 Topline: A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety
Phase 1 StartPhase 1 Start: A Phase I, Open-label Study to Assess the Absorption, Distribution, Metabolism, and Excretion (ADME)

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 1 Start: A Phase I, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokin — AZN Phase 1 Start | BioSniper